Gene Therapy Study for Children With CLN5 Batten Disease
Clinical trial NCT05228145 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05228145
- Sponsor
- Neurogene Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-31
- Primary completion
- 2028-11-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.